The AI in medical writing market size was valued at USD 869.05 million in 2024 and is expected to reach USD 2240.06 million by 2032, growing at a CAGR of 12.58% over 2025-2032.
The AI in medical writing market trends include gaining traction due to the growing number of clinical trials globally, the increasing number of regulatory documents, and increased R&D spending in the pharmaceutical and biotechnology industries. AI technologies form the basis of interesting solutions, such as natural language processing (NLP), machine learning (ML), and generative AI, which are transforming the way clinical study reports, regulatory submissions, and scientific articles are authored.
In April 2025, Indegene augmented its AI technology with a proprietary generative AI platform for regulatory writing, which integrates real-time compliance checks and format uniformity into the solution.
With the pharmaceutical industry still spending tens of billions of dollars per year, more than USD 244 billion globally in 2024, according to Evaluate Pharma on drug discovery and clinical development, the amount of documentation generated in this area is increasing exponentially, and demand for effective AI-based writing solutions is increasing accordingly. Authorities are now recognizing structured AI-assisted documents for quicker approvals, enabling an easy and automated compliance process.
In addition, a lack of quality medical writers and the expense and time of manual documentation have led pharma and biotech companies to increasingly turn to AI platforms. AI in medical writing companies are also focusing on technological advancements, inorganic strategies, developments, and business operations toward the global AI in medical writing market share. Increasing research and development (R&D) activities, technological advancements in AI in the medical writing field, and new product launches are contributing to the future AI in medical writing market trends. The market is spurred by accuracy, speed, scalability, and compliance, which continue to drive its growth.
In May 2025, the primary end-point was met with the introduction by Parexel of an AI-driven clinical documentation suite that automates the generation of patient narratives and CSRs and reduces the time required for documentation by 40%.
Table: Shows How AI Technology in Medical Writing Has Evolved and Will Grow
|
Year |
Key Innovation |
Impact |
|
2021 |
Introduction of NLP-based summarisation |
Faster clinical report generation |
|
2023 |
Integration with EHR systems |
Real-time data access for writers |
|
2025 |
Generative AI platforms (e.g., GPT-style) |
Full draft automation of safety docs |
|
2027 (est.) |
AI regulation by global health authorities |
Streamlined cross-border compliance |
|
2030 (est.) |
Autonomous report writing with/ minimal input |
70% reduction in production time |
Market Dynamics:
Drivers:
Rising Demand for Automation, Regulatory Compliance, and Growing R&D Burden Propel Market Growth
The AI in medical writing market is largely driven by the growing need for the automation of scientific and clinical documentation and an increasing emphasis on the creation of high-quality medical documents in the pharmaceutical and biotechnology industry. The need to analyze thousands of pages of regulatory and clinical documentation per trial has led to an increased demand for AI-driven solutions.
Drug development costs on average over USD 2.6 billion, and documentation is a significant portion of both time and cost. Content creation time can be cut by 40% with AI-enabled platforms, accuracy is improved, and the platform supports compliance with highly complex regulatory standards, including ICH E3 and PMDA’s eCTD guidance specification are all factors which are contributing to the growth of the AI in medical writing market. The fusion of NLP and ML in writing processes is also enhancing consistency and data auditability.
Tech players and CROs are spending big, north of USD 4 billion in AI healthcare tools in 2024, on solutions that simplify protocol writing, investigator brochures, and CSR generation. Moreover, increasing preference for real-time analytics and AI-based editing solutions by AI in medical writing industry players, including BioLamina and HealthVerity, further contributes to the AI in medical writing market share. Such a high demand, investment, and regulatory needs, in turn, generate an increasing demand for the global AI in medical writing market.
Restraints:
Data Privacy Concerns, Validation Complexities, and Skill Gaps Hindering Market Expansion
The AI in medical writing market analysis is emerging, though it is hindered by macro-socio-economic factors, such as stringent data privacy laws, a lack of human supervision, and verification issues of AI-composed content. AI platforms heavily depend on large sets of data (such as patient files, trial results), and therefore, data protection becomes a major concern, especially when placed under global regulations like GDPR, HIPAA, and 21 CFR part 11. Such laws regulate strict data security control and have made it challenging for AI in medical writing companies to use scalable models without non-compliant risks.
In addition, AI-model outputs are typically unable to be easily interpreted and require extensive quality assurance before they can be considered for use in the regulatory filings, thereby delaying integration. More than 65% of clinical trial organizations highlighted a shortage of skills and training as one of the main problems in implementing AI, according to a 2024 study by McKinsey. There is also a lot of trepidation around AI replacing the subtlety of human medical writers, especially in difficult therapeutic areas.
The AI in medical writing market analysis also indicates a lack of medical professionals’ literacy in AI, which acts as a barrier to a wide deployment. Rising investment costs for initial investments for AI platforms and training of models, along with the absence of standardised validation frameworks, are a few of the factors that further impede the AI in medical writing market growth. These reasons combine to hinder the scale of the global AI in medical writing market despite its promise and potential.
By Type
The typewriting type was the segment that covered the largest share of revenue, with 33.02% of the AI in medical writing market in 2024. This popularity is a consequence of the popular contemporary usage of AI-infused tools for the conversion of medical notes, reports, and other forms of documentation from voice to text, contributing towards the increased productivity and reduced manual labor in clinical settings. Healthcare SMEs and practitioners are also more commonly using typewriting systems that make use of AI, such as intelligent typewriting tools to ensure rapid TATs and more accurate documentation.
The clinical writing segment, however, is projected to register the highest CAGR owing to mounting complexity in clinical trials and increasing demand for AI-based support to develop clinical study reports (CSRs), investigator brochures, and patient narratives. This growth in automation is being driven by the use of AI tools in CROs and life sciences companies to create clinical content, as they improve consistency and adherence to regulatory requirements.
By End-Use
The pharmaceutical end-user type was the leading revenue-generating segment, accounting for 33.37% share in the AI in medical writing market in 2024, led by the high volume of regulatory submissions, labelling documents, and scientific publications in the industry. Pharma companies are increasingly implementing AI solutions to cope with the growing volume of documentation in drug development, from discovery to post-market surveillance.
In contrast, the medical devices segment is expected to experience the most rapid growth due to a rise in product innovations and global regulations that require accurate and timely technical documentation. AI is now used to create more efficient regulatory writing, particularly post-market surveillance reports, for medical device manufacturers who need to maintain both compliance and competitiveness in a changing world.
Regional Analysis:
The Asia Pacific AI in medical writing market was the global market leader, in terms of revenue share, capturing close to 30.47% of the share in 2024, owing to rising clinical trial activity, higher outsourcing from the Western part of the globe and rapid implementation of AI solutions by regional pharmaceutical and biotechnology companies. The area has access to a rich pool of talented medical professionals and inexpensive AI development centres. India leads the game in this with a robust community of CROs and a growing number of AI healthcare startups, due to state-led digital health programmes. China also learnt from its near-total seizure of the SARS-CoV-2 market globally, due to massive investment in AI infrastructure and the large-scale expansion of its pharma sector. The rapidly growing APAC is experiencing increasing demand for AI-powered documentation tools, due to a rise in life sciences research, multilingual writing ability, and digitised healthcare systems.
The North America AI in medical writing market size is growing substantially on account of excellent healthcare infrastructure, large AI R&D funding and adoption by leading pharmaceutical companies.
The U.S. AI in medical writing market size was valued at USD 170.73 million in 2024 and is expected to reach USD 465.27 million by 2032, growing at a CAGR of 13.40% over 2025-2032. The U.S. accounts for the largest share of the regional market on the back of high R&D spending, more than USD 86 billion in biopharma R&D in 2024, and the presence of prominent AI in medical writing industry players, such as IBM Watson Health and Oracle Health Sciences. Regulatory leeway from organizations, including the FDA, for instance, which supports the integration of AI into clinical documentation, is another important ingredient. Canada is fast becoming a hub as it invests in AI ethics and regulatory tech standards. North America is second globally in growth because it has a mature market, regulatory frameworks, and a robust innovation pipeline.
Europe is growing at a steady pace in the AI in medical writing market, and the increasing adoption in pharmaceutical and academic research organizations is driving the market growth. The area benefits from pan-EU digital healthcare programmes and a solid clinical research infrastructure. The European market is led by Germany owing to the country's superior pharma manufacturing sector and growing AI usage in regulatory and scientific documentation. The U.K. is also noteworthy for the uptake of AI tools in the context of NHS-led research projects and clinical trials. Growth in Europe is driven by high EMA compliance and AI startups partnering with CROs on the rise. The next is the emphasis on multilingual AI, which also makes them more acceptable across the continent.
Table: Indicates Levels of Adoption and Growth Intensity for AI In Medical Writing
|
Region |
Adoption Level (2024) |
Growth Status |
Leading Country |
Notes |
|
North America |
High |
Moderate |
United States |
Strong pharma sector, early AI integration |
|
Europe |
Medium-High |
High |
UK & Germany |
Regulatory alignment + AI R&D funding |
|
Asia Pacific |
High |
Very High |
China, India, Japan |
Digital infrastructure and pharma expansion |
|
Latin America |
Moderate |
Emerging |
Brazil |
Growing interest in bilingual documentation |
|
Middle East & Africa |
Emerging |
Moderate |
UAE, South Africa |
Government AI health investments growing |
Leading AI in medical writing companies in the market include Certara, Parexel International, Trilogy Writing & Consulting, Cactus Communications, Freyr, GENINVO, IQVIA Inc., ICON plc, Syneos Health, and Teladoc Health.
In November 2024, Paris-based startup Biolevate secured USD 6.42 million in funding to enhance its AI-assisted medical writing platform, aimed at streamlining regulatory and clinical documentation in life sciences.
In May 2024, Indegene launched CORTEX.AI, an advanced AI platform tailored for the life sciences industry, enabling automation in medical writing, regulatory submissions, and commercial content creation.
| Report Attributes | Details |
|---|---|
| Market Size in 2024 | USD 869.05 million |
| Market Size by 2032 | USD 2240.06 million |
| CAGR | CAGR of 12.58% From 2025 to 2032 |
| Base Year | 2024 |
| Forecast Period | 2025-2032 |
| Historical Data | 2021-2023 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Type (Clinical Writing, Typewriting, Scientific Writing, and Others) • By End Use (Medical Devices, Pharmaceutical, Biotechnology, and Others) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, Poland, Turkey, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) |
| Company Profiles | Certara, Parexel International, Trilogy Writing & Consulting, Cactus Communications, Freyr, GENINVO, IQVIA Inc., ICON plc, Syneos Health, and Teladoc Health |
Ans: The AI in medical writing market size was valued at USD 869.05 million in 2024 and is projected to reach USD 2240.06 million by 2032, growing at a CAGR of 12.58% from 2025 to 2032.
Ans: Key players include Parexel International, Certara, IQVIA, ICON plc, Syneos Health, Freyr, Cactus Communications, GENINVO, IBM, and Teladoc Health.
Ans: Investments are increasing in AI-driven content platforms, with companies like Biolevate, Indegene, and Aingens raising capital or launching AI tools to improve regulatory and clinical documentation efficiency.
Ans: The market is expected to grow at a CAGR of 12.58% from 2025 to 2032, driven by rising demand for automation and regulatory compliance.
Ans: AI reduces documentation time by up to 40%, lowers human error, and enhances regulatory compliance, significantly improving both cost-efficiency and productivity for life sciences companies.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.2 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Adoption Rate of AI in Medical Writing (2024)
5.2 Application Trends by Region (2024)
5.3 Time Savings & Efficiency Gains (2024)
5.4 Compliance & Error Reduction Metrics (2024)
5.5 Talent & Workforce Trends in Medical Writing (2024)
5.6 Healthcare IT Spending on AI in Medical Writing, by Region (Government, Commercial, Private), 2024
6. Competitive Landscape
6.1 List of Major Companies By Region
6.2 Market Share Analysis By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and Supply Chain Strategies
6.4.3 Expansion Plans and New Product Launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. AI In Medical Writing Market Segmentation By Type
7.1 Chapter Overview
7.2 Clinical Writing
7.2.1 Clinical Writing Market Trend Analysis (2021-2032)
7.2.2 Clinical Writing Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Typewriting
7.3.1 Typewriting Market Trends Analysis (2021-2032)
7.3.2 Typewriting Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4 Scientific Writing
7.4.1 Scientific Writing Market Trends Analysis (2021-2032)
7.4.2 Scientific Writing Market Size Estimates and Forecasts to 2032 (USD Billion)
7.5 Others
7.5.1 Others Market Trends Analysis (2021-2032)
7.5.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
8. AI In Medical Writing Market Segmentation by End Use
8.1 Chapter Overview
8.2 Medical Devices
8.2.1 Medical Devices Market Trends Analysis (2021-2032)
8.2.2 Medical Devices Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Pharmaceutical
8.3.1 Pharmaceutical Market Trends Analysis (2021-2032)
8.3.2 Pharmaceutical Market Size Estimates and Forecasts to 2032 (USD Billion)
8.4 Biotechnology
8.4.1 Biotechnology Market Trends Analysis (2021-2032)
8.4.2 Biotechnology Market Size Estimates and Forecasts to 2032 (USD Billion)
8.5 Others
8.5.1 Others Market Trends Analysis (2021-2032)
8.5.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
9. Regional Analysis
9.1 Chapter Overview
9.2 North America
9.2.1 Trends Analysis
9.2.2 North America AI In Medical Writing Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)
9.2.3 North America AI In Medical Writing Market Estimates and Forecasts, By Type (2021-2032) (USD Billion)
9.2.4 North America AI In Medical Writing Market Estimates and Forecasts, by End Use (2021-2032) (USD Billion)
9.2.5 USA
9.2.5.1 USA AI In Medical Writing Market Estimates and Forecasts, By Type (2021-2032) (USD Billion)
9.2.5.2 USA AI In Medical Writing Market Estimates and Forecasts, by End Use (2021-2032) (USD Billion)
9.2.6 Canada
9.2.6.1 Canada AI In Medical Writing Market Estimates and Forecasts, By Type (2021-2032) (USD Billion)
9.2.6.2 Canada AI In Medical Writing Market Estimates and Forecasts, by End Use (2021-2032) (USD Billion)
9.2.7 Mexico
9.2.7.1 Mexico AI In Medical Writing Market Estimates and Forecasts, By Type (2021-2032) (USD Billion)
9.2.7.2 Mexico AI In Medical Writing Market Estimates and Forecasts, by End Use (2021-2032) (USD Billion)
9.3 Europe
9.3.1 Trends Analysis
9.3.2 Europe AI In Medical Writing Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)
9.3.3 Europe AI In Medical Writing Market Estimates and Forecasts, By Type (2021-2032) (USD Billion)
9.3.4 Europe AI In Medical Writing Market Estimates and Forecasts, by End Use (2021-2032) (USD Billion)
9.3.5 Germany
9.3.5.1 Germany AI In Medical Writing Market Estimates and Forecasts, By Type (2021-2032) (USD Billion)
9.3.5.2 Germany AI In Medical Writing Market Estimates and Forecasts, by End Use (2021-2032) (USD Billion)
9.3.6 France
9.3.6.1 France AI In Medical Writing Market Estimates and Forecasts, By Type (2021-2032) (USD Billion)
9.3.6.2 France AI In Medical Writing Market Estimates and Forecasts, by End Use (2021-2032) (USD Billion)
9.3.7 UK
9.3.7.1 UK AI In Medical Writing Market Estimates and Forecasts, By Type (2021-2032) (USD Billion)
9.3.7.2 UK AI In Medical Writing Market Estimates and Forecasts, by End Use (2021-2032) (USD Billion)
9.3.8 Italy
9.3.8.1 Italy AI In Medical Writing Market Estimates and Forecasts, By Type (2021-2032) (USD Billion)
9.3.8.2 Italy AI In Medical Writing Market Estimates and Forecasts, by End Use (2021-2032) (USD Billion)
9.3.9 Spain
9.3.9.1 Spain AI In Medical Writing Market Estimates and Forecasts, By Type (2021-2032) (USD Billion)
9.3.9.2 Spain AI In Medical Writing Market Estimates and Forecasts, by End Use (2021-2032) (USD Billion)
9.3.10 Poland
9.3.10.1 Poland AI In Medical Writing Market Estimates and Forecasts, By Type (2021-2032) (USD Billion)
9.3.10.2 Poland AI In Medical Writing Market Estimates and Forecasts, by End Use (2021-2032) (USD Billion)
9.3.11 Turkey
9.3.11.1 Turkey AI In Medical Writing Market Estimates and Forecasts, By Type (2021-2032) (USD Billion)
9.3.11.2 Turkey AI In Medical Writing Market Estimates and Forecasts, by End Use (2021-2032) (USD Billion)
9.3.12 Rest of Europe
9.3.12.1 Rest of Europe AI In Medical Writing Market Estimates and Forecasts, By Type (2021-2032) (USD Billion)
9.3.12.2 Rest of Europe AI In Medical Writing Market Estimates and Forecasts, by End Use (2021-2032) (USD Billion)
9.4 Asia Pacific
9.4.1 Trends Analysis
9.4.2 Asia Pacific AI In Medical Writing Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)
9.4.3 Asia Pacific AI In Medical Writing Market Estimates and Forecasts, By Type (2021-2032) (USD Billion)
9.4.4 Asia Pacific AI In Medical Writing Market Estimates and Forecasts, by End Use (2021-2032) (USD Billion)
9.4.5 China
9.4.5.1 China AI In Medical Writing Market Estimates and Forecasts, By Type (2021-2032) (USD Billion)
9.4.5.2 China AI In Medical Writing Market Estimates and Forecasts, by End Use (2021-2032) (USD Billion)
9.4.6 India
9.4.5.1 India AI In Medical Writing Market Estimates and Forecasts, By Type (2021-2032) (USD Billion)
9.4.5.2 India AI In Medical Writing Market Estimates and Forecasts, by End Use (2021-2032) (USD Billion)
9.4.5 Japan
9.4.5.1 Japan AI In Medical Writing Market Estimates and Forecasts, By Type (2021-2032) (USD Billion)
9.4.5.2 Japan AI In Medical Writing Market Estimates and Forecasts, by End Use (2021-2032) (USD Billion)
9.4.6 South Korea
9.4.6.1 South Korea AI In Medical Writing Market Estimates and Forecasts, By Type (2021-2032) (USD Billion)
9.4.6.2 South Korea AI In Medical Writing Market Estimates and Forecasts, by End Use (2021-2032) (USD Billion)
9.4.7 Singapore
9.4.7.1 Singapore AI In Medical Writing Market Estimates and Forecasts, By Type (2021-2032) (USD Billion)
9.4.7.2 Singapore AI In Medical Writing Market Estimates and Forecasts, by End Use (2021-2032) (USD Billion)
8.4.8 Australia
8.4.8.1 Australia AI In Medical Writing Market Estimates and Forecasts, By Type (2021-2032) (USD Billion)
8.4.8.2 Australia AI In Medical Writing Market Estimates and Forecasts, by End Use (2021-2032) (USD Billion)
9.4.9 Rest of Asia Pacific
9.4.9.1 Rest of Asia Pacific AI In Medical Writing Market Estimates and Forecasts, By Type (2021-2032) (USD Billion)
9.4.9.2 Rest of Asia Pacific AI In Medical Writing Market Estimates and Forecasts, by End Use (2021-2032) (USD Billion)
9.5 Middle East & Africa
9.5.1 Trends Analysis
9.5.2 Middle East & Africa AI In Medical Writing Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)
9.5.3 Middle East & Africa AI In Medical Writing Market Estimates and Forecasts, By Type (2021-2032) (USD Billion)
9.5.4 Middle East & Africa AI In Medical Writing Market Estimates and Forecasts, by End Use (2021-2032) (USD Billion)
9.5.5 UAE
9.5.5.1 UAE AI In Medical Writing Market Estimates and Forecasts, By Type (2021-2032) (USD Billion)
9.5.5.2 UAE AI In Medical Writing Market Estimates and Forecasts, by End Use (2021-2032) (USD Billion)
9.5.6 Saudi Arabia
9.5.6.1 Saudi Arabia AI In Medical Writing Market Estimates and Forecasts, By Type (2021-2032) (USD Billion)
9.5.6.2 Saudi Arabia AI In Medical Writing Market Estimates and Forecasts, by End Use (2021-2032) (USD Billion)
9.5.7 Qatar
9.5.7.1 Qatar AI In Medical Writing Market Estimates and Forecasts, By Type (2021-2032) (USD Billion)
9.5.7.2 Qatar AI In Medical Writing Market Estimates and Forecasts, by End Use (2021-2032) (USD Billion)
9.5.8 South Africa
9.5.8.1 South Africa AI In Medical Writing Market Estimates and Forecasts, By Type (2021-2032) (USD Billion)
9.5.8.2 South Africa AI In Medical Writing Market Estimates and Forecasts, by End Use (2021-2032) (USD Billion)
9.5.9 Middle East & Africa
9.5.9.1 Middle East & Africa AI In Medical Writing Market Estimates and Forecasts, By Type (2021-2032) (USD Billion)
9.5.9.2 Middle East & Africa AI In Medical Writing Market Estimates and Forecasts, by End Use (2021-2032) (USD Billion)
9.6 Latin America
9.6.1 Trends Analysis
9.6.2 Latin America AI In Medical Writing Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)
9.6.3 Latin America AI In Medical Writing Market Estimates and Forecasts, By Type (2021-2032) (USD Billion)
9.6.4 Latin America AI In Medical Writing Market Estimates and Forecasts, by End Use (2021-2032) (USD Billion)
9.6.5 Brazil
9.6.5.1 Brazil AI In Medical Writing Market Estimates and Forecasts, By Type (2021-2032) (USD Billion)
9.6.5.2 Brazil AI In Medical Writing Market Estimates and Forecasts, by End Use (2021-2032) (USD Billion)
9.6.6 Argentina
9.6.6.1 Argentina AI In Medical Writing Market Estimates and Forecasts, By Type (2021-2032) (USD Billion)
9.6.6.2 Argentina AI In Medical Writing Market Estimates and Forecasts, by End Use (2021-2032) (USD Billion)
9.6.7 Rest of Latin America
9.6.7.1 Rest of Latin America AI In Medical Writing Market Estimates and Forecasts, By Type (2021-2032) (USD Billion)
9.6.7.2 Rest of Latin America AI In Medical Writing Market Estimates and Forecasts, by End Use (2021-2032) (USD Billion)
10. Company Profiles
10.1 Certara
10.1.1 Company Overview
10.1.2 Financial
10.1.3 Product / Services Offered
10.1.4 SWOT Analysis
10.2 Parexel International
10.2.1 Company Overview
10.2.2 Financial
10.2.3 Product/ Services Offered
10.2.4 SWOT Analysis
10.3 Trilogy Writing & Consulting
10.3.1 Company Overview
10.3.2 Financial
10.3.3 Product/ Services Offered
10.3.4 SWOT Analysis
10.4 Cactus Communications
10.4.1 Company Overview
10.4.2 Financial
10.4.3 Product/ Services Offered
10.4.4 SWOT Analysis
10.5 Freyr
10.5.1 Company Overview
10.5.2 Financial
10.5.3 Product/ Services Offered
10.5.4 SWOT Analysis
10.6 GENINVO
10.6.1 Company Overview
10.6.2 Financial
10.6.3 Product/ Services Offered
10.6.4 SWOT Analysis
10.7 IQVIA Inc.
10.7.1 Company Overview
10.7.2 Financial
10.7.3 Product/ Services Offered
10.7.4 SWOT Analysis
10.8 ICON plc
10.8.1 Company Overview
10.8.2 Financial
10.8.3 Product/ Services Offered
10.8.4 SWOT Analysis
10.9 Syneos Health
10.9.1 Company Overview
10.9.2 Financial
10.9.3 Product/ Services Offered
10.9.4 SWOT Analysis
10.10 Teladoc Health
10.10.1 Company Overview
10.10.2 Financial
10.10.3 Product/ Services Offered
10.10.4 SWOT Analysis
11. Use Cases and Best Practices
12. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
Key Segments
By Type
Clinical Writing
Typewriting
Scientific Writing
Others
By End Use
Medical Devices
Pharmaceutical
Biotechnology
Others
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
US
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Poland
Turkey
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
UAE
Saudi Arabia
Qatar
South Africa
Rest of Middle East & Africa
Latin America
Brazil
Argentina
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Detailed Volume Analysis
Criss-Cross segment analysis (e.g., Product X Application)
Competitive Product Benchmarking
Geographic Analysis
Additional countries in any of the regions
Customized Data Representation
Detailed analysis and profiling of additional market players